| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-84 |
Sentence |
denotes |
STAT1 modification improves therapeutic effects of interferons on lung cancer cells. |
| T1 |
0-84 |
Sentence |
denotes |
STAT1 modification improves therapeutic effects of interferons on lung cancer cells. |
| TextSentencer_T2 |
85-96 |
Sentence |
denotes |
BACKGROUND: |
| T2 |
85-96 |
Sentence |
denotes |
BACKGROUND: |
| TextSentencer_T3 |
97-210 |
Sentence |
denotes |
Interferons (IFNs) have potent anti-proliferative, pro-apoptotic, and immunomodulatory activities against cancer. |
| T3 |
97-210 |
Sentence |
denotes |
Interferons (IFNs) have potent anti-proliferative, pro-apoptotic, and immunomodulatory activities against cancer. |
| TextSentencer_T4 |
211-380 |
Sentence |
denotes |
However, the clinical utility of IFNs is limited by toxicity and pharmacokinetics making it difficult to achieve sustained therapeutic levels especially in solid tumors. |
| T4 |
211-380 |
Sentence |
denotes |
However, the clinical utility of IFNs is limited by toxicity and pharmacokinetics making it difficult to achieve sustained therapeutic levels especially in solid tumors. |
| TextSentencer_T5 |
381-389 |
Sentence |
denotes |
METHODS: |
| T5 |
381-389 |
Sentence |
denotes |
METHODS: |
| TextSentencer_T6 |
390-606 |
Sentence |
denotes |
Signal Transducer and Activator of Transcription 1 (STAT1) or a modified STAT1 (designated STAT1-CC) that is hyper-responsive to IFN were overexpressed in lung cancer SPC-A-1 and H1299 cells using lentiviral vectors. |
| T6 |
390-606 |
Sentence |
denotes |
Signal Transducer and Activator of Transcription 1 (STAT1) or a modified STAT1 (designated STAT1-CC) that is hyper-responsive to IFN were overexpressed in lung cancer SPC-A-1 and H1299 cells using lentiviral vectors. |
| TextSentencer_T7 |
607-704 |
Sentence |
denotes |
Transduction efficiency was monitored using enhanced green fluorescent protein (EGFP) expression. |
| T7 |
607-704 |
Sentence |
denotes |
Transduction efficiency was monitored using enhanced green fluorescent protein (EGFP) expression. |
| TextSentencer_T8 |
705-984 |
Sentence |
denotes |
After transduction, cells were treated with interferon-gamma (IFN-γ) or interferon-beta (IFN-β) and monitored for cell proliferation, migration, and invasiveness using Cell Counting Kit-8 and transwell chamber assays and for apoptosis using Annexin V detection by flow cytometry. |
| T8 |
705-984 |
Sentence |
denotes |
After transduction, cells were treated with interferon-gamma (IFN-γ) or interferon-beta (IFN-β) and monitored for cell proliferation, migration, and invasiveness using Cell Counting Kit-8 and transwell chamber assays and for apoptosis using Annexin V detection by flow cytometry. |
| TextSentencer_T9 |
985-1121 |
Sentence |
denotes |
In addition, levels of STAT1, STAT1 Tyr-701 phosphorylation (pSTAT1), fibronectin, and β-catenin were determined using western blotting. |
| T9 |
985-1121 |
Sentence |
denotes |
In addition, levels of STAT1, STAT1 Tyr-701 phosphorylation (pSTAT1), fibronectin, and β-catenin were determined using western blotting. |
| TextSentencer_T10 |
1122-1259 |
Sentence |
denotes |
In the case of IFN-γ stimulation, levels of S100A4, proliferating cell nuclear antigen (PCNA), and c-fos expression were also determined. |
| T10 |
1122-1259 |
Sentence |
denotes |
In the case of IFN-γ stimulation, levels of S100A4, proliferating cell nuclear antigen (PCNA), and c-fos expression were also determined. |
| TextSentencer_T11 |
1260-1268 |
Sentence |
denotes |
RESULTS: |
| T11 |
1260-1268 |
Sentence |
denotes |
RESULTS: |
| TextSentencer_T12 |
1269-1437 |
Sentence |
denotes |
We found that expression of STAT1 or STAT1-CC enhanced the effect of IFN-γ and, IFN-β on inhibition of human lung cancer cell proliferation, migration and invasiveness. |
| T12 |
1269-1437 |
Sentence |
denotes |
We found that expression of STAT1 or STAT1-CC enhanced the effect of IFN-γ and, IFN-β on inhibition of human lung cancer cell proliferation, migration and invasiveness. |
| TextSentencer_T13 |
1438-1555 |
Sentence |
denotes |
Moreover, STAT1 and STAT1-CC expression caused increases in pSTAT1 and decreases in fibronectin and β-catenin levels. |
| T13 |
1438-1555 |
Sentence |
denotes |
Moreover, STAT1 and STAT1-CC expression caused increases in pSTAT1 and decreases in fibronectin and β-catenin levels. |
| TextSentencer_T14 |
1556-1686 |
Sentence |
denotes |
STAT1-CC showed increased effects compared to STAT1 on IFN-γ induced pSTAT1 and down-regulation of S100A4, PCNA, and c-fos levels. |
| T14 |
1556-1686 |
Sentence |
denotes |
STAT1-CC showed increased effects compared to STAT1 on IFN-γ induced pSTAT1 and down-regulation of S100A4, PCNA, and c-fos levels. |
| TextSentencer_T15 |
1687-1698 |
Sentence |
denotes |
CONCLUSION: |
| T15 |
1687-1698 |
Sentence |
denotes |
CONCLUSION: |
| TextSentencer_T16 |
1699-1819 |
Sentence |
denotes |
The results show that STAT1-CC exhibited more strength in improving the antitumor response of IFNs in lung cancer cells. |
| T16 |
1699-1819 |
Sentence |
denotes |
The results show that STAT1-CC exhibited more strength in improving the antitumor response of IFNs in lung cancer cells. |
| TextSentencer_T17 |
1820-1983 |
Sentence |
denotes |
Results from this study suggest that combined treatment of IFNs and STAT1-CC might be a feasible approach for the clinical management of lung cancer in the future. |
| T17 |
1820-1983 |
Sentence |
denotes |
Results from this study suggest that combined treatment of IFNs and STAT1-CC might be a feasible approach for the clinical management of lung cancer in the future. |